![Adriana Manzi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Adriana Manzi
Präsident bei Manzi & Associates LLC
Aktive Positionen von Adriana Manzi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Manzi & Associates LLC
![]() Manzi & Associates LLC Miscellaneous Commercial ServicesCommercial Services Manzi & Associates LLC provides accounting services. | Präsident | 01.06.2006 | - |
Karriereverlauf von Adriana Manzi
Ehemalige bekannte Positionen von Adriana Manzi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Baxter Healthcare Corp.
![]() Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01.01.2006 | 01.01.2006 |
University of California | Corporate Officer/Principal | - | - |
Nextran
![]() Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Corporate Officer/Principal | - | - |
Iconic Therapeutics, Inc.
![]() Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2008 | - |
Ausbildung von Adriana Manzi
University of California San Diego | Doctorate Degree |
Universidad de Buenos Aires | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Argentinien | 2 |
Operativ
Corporate Officer/Principal | 4 |
Doctorate Degree | 2 |
President | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Iconic Therapeutics, Inc.
![]() Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Manzi & Associates LLC
![]() Manzi & Associates LLC Miscellaneous Commercial ServicesCommercial Services Manzi & Associates LLC provides accounting services. | Commercial Services |
Baxter Healthcare Corp.
![]() Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Nextran
![]() Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Health Technology |
- Börse
- Insiders
- Adriana Manzi
- Erfahrung